发明名称 |
Antibodies to OX-2/CD200 and uses thereof in inhibiting immune responses |
摘要 |
This disclosure provides methods and compositions for inhibiting immune responses. The disclosure also provides methods and compositions for inhibiting graft rejection and promoting or prolonging graft survival. |
申请公布号 |
USRE46323(E1) |
申请公布日期 |
2017.02.28 |
申请号 |
US201314080457 |
申请日期 |
2013.11.14 |
申请人 |
Alexion Pharmaceuticals, Inc. |
发明人 |
Rother Russell P.;Faas McKnight Susan |
分类号 |
A61K39/395;C07K16/28;A61K39/00 |
主分类号 |
A61K39/395 |
代理机构 |
Nelson Mullins Riley & Scarborough LLP |
代理人 |
Nelson Mullins Riley & Scarborough LLP ;Remillard, Esq. Jane E.;Frank Christopher L. |
主权项 |
1. A method of inhibiting an immune response in a subject who has received or will receive a cell, tissue, or organ transplant, wherein said method comprises administering to the subject an effective amount of i) an agent which inhibits interaction between CD200 and CD200R and ii) an immunosuppressive id="REI-00012" date="20170228" orid="REI-00012" drug, wherein the agent is an anti-CD200 antibody, or antigen-binding fragment thereof, exhibiting reduced effector function. |
地址 |
New Haven CT US |